Sintx Technologies, Inc. — Capital/Financing Update 2017

Jan 24, 2017

8-K 1 form8-k.htm

Field: Rule-Page

Field: /Rule-Page

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): January 24, 2017

AMEDICA CORPORATION (Exact name of registrant as specified in its charter)

Delaware	001-33624	84-1375299
(State
or other jurisdiction of	(Commission	(IRS
Employer
incorporation)	File
Number)	Identification
No.)

1885 West 2100 South

Salt Lake City, UT 84119

(Address of principal executive offices, including Zip Code)

Registrant’s telephone number, including area code: (801) 839-3500

N/A (Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

| [ ] | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | | --- | --- | | [ ] | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | | [ ] | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | | [ ] | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |

Field: Rule-Page

Field: /Rule-Page

Field: Page; Sequence: 1

Field: /Page

Item 1.01 Entry into a Material Definitive Agreement

On January 24, 2017, Amedica Corporation closed (the “Closing”) its previously announced underwritten public offering (the “Offering”) of 8,900,000 shares of its common stock and warrants to purchase 4,005,000 shares of its common stock. In connection with the Closing, the Company entered into a warrant agency agreement with American Stocker Transfer & Trust Co. (“AST”), pursuant to which AST will serve as warrant agent for the warrants issued in the Offering. A copy of the Warrant Agency Agreement is attached to this report as Exhibit 10.1 and incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.

| Exhibit

No.	Description
10.1	Warrant
Agency Agreement dated January 24, 2017

Field: Page; Sequence: 2

Field: /Page

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

| /s/

B. Sonny Bal
B.
Sonny Bal
Chief
Executive Officer

Field: Page; Sequence: 3

Field: /Page

EXHIBIT INDEX

| Exhibit No . | Exhibit Description | | --- | --- | | 10.1 | Warrant Agency Agreement dated January 24, 2017 |

Field: Page; Sequence: 4

Field: /Page